FDA clearance is a critical regulatory milestone that can significantly impact a medical device company's prospects. For Zynex, this approval not only validates the M-Wave device's safety and efficacy but also potentially opens up new market opportunities and enhances its competitive position. Given the importance of regulatory approvals in the healthcare sector, this news is likely to be viewed positively by investors, potentially leading to a short-term uptick in ZYXI's stock price.